Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver-Reference-Cited by-同舟云学术

Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver

Published:2011-05 Issue:5 Volume:54 Page:975-983
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Iacobini Carla,Menini Stefano,Ricci Carlo,Fantauzzi Claudia Blasetti,Scipioni Angela,Salvi Laura,Cordone Samantha,Delucchi Francesca,Serino Matteo,Federici Massimo,Pricci Flavia,Pugliese Giuseppe

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Nonalcoholic fatty liver disease;Erickson;J Lipid Res,2009

2. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome;Marchesini;Hepatology,2003

3. Lipid metabolism in hepatic steatosis;Bradbury;Clin Liver Dis,2004

4. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research;Anstee;Int J Exp Pathol,2006

5. Beyond insulin resistance. Innate immunity in nonalcoholic steatohepatitis;Maher;Hepatology,2008

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics;Livers;2024-09-13

2. Protective effect of Galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes;Archives of Physiology and Biochemistry;2024-08-05

3. The detrimental role of galectin‐3 and endoplasmic reticulum stress in the cardiac consequences of myocardial ischemia in the context of obesity;The FASEB Journal;2024-07-11

4. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

5. Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study;International Journal of Obesity;2024-05-22